Form 8-K - Current report:
SEC Accession No. 0001140361-23-009748
Filing Date
2023-03-02
Accepted
2023-03-02 16:16:32
Documents
15
Period of Report
2023-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10049211_8k.htm   iXBRL 8-K 43863
2 EXHIBIT 10.1 brhc10049211_ex10-1.htm EX-10.1 294442
3 EXHIBIT 99.1 brhc10049211_ex99-1.htm EX-99.1 17014
7 image0.jpg GRAPHIC 91687
  Complete submission text file 0001140361-23-009748.txt   694969

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cbio-20230227.xsd EX-101.SCH 3907
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20230227_lab.xml EX-101.LAB 22546
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20230227_pre.xml EX-101.PRE 16072
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10049211_8k_htm.xml XML 4211
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 23699143
SIC: 2834 Pharmaceutical Preparations